Cargando…

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis

Invasive meningococcal disease (IMD) caused by Neisseria meningitidis (Nm) continues to be a global public health concern. Understanding the prevalence of Nm serogroups in IMD is critical for developing strategies for meningococcal vaccination. We used the keywords “cerebrospinal meningitis”, “menin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Juan, Chen, Yuquan, Yue, Mengmeng, Yu, Jianxing, Han, Fuyi, Xu, Li, Shao, Zhujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Meningococcal – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302495/ https://www.ncbi.nlm.nih.gov/pubmed/35687866 http://dx.doi.org/10.1080/21645515.2022.2071077

Ejemplares similares

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam
por: The Nguyen, Phung Nguyen, et al.
Publicado: (2023)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Neisseria meningitidis Serogroup W135, China
por: Shao, Zhujun, et al.
Publicado: (2010)

Neisseria meningitidis Strain of Unknown Serogroup, China
por: Zhou, Haijian, et al.
Publicado: (2011)

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination
por: Tan, Litjen (L.J), et al.
Publicado: (2023)

Meningococcal burden of disease in Argentina: 10 years epidemiologic review
por: Neyro, Silvina, et al.
Publicado: (2023)

Carriage prevalence of Neisseria meningitidis in China, 2005–2022: a systematic review and meta-analysis
por: Yue, Mengmeng, et al.
Publicado: (2022)

Spread of Neisseria meningitidis Serogroup W Clone, China
por: Zhou, Haijian, et al.
Publicado: (2013)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
por: Dubey, Anand P., et al.
Publicado: (2022)

Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model
por: Régnier, Stéphane A, et al.
Publicado: (2014)

Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010–2016
por: Lee, Hyukmin, et al.
Publicado: (2018)

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
por: Robertson, Corwin A., et al.
Publicado: (2023)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Increase in Neisseria meningitidis Serogroup W135, Niger, 2010
por: Collard, Jean-Marc, et al.
Publicado: (2010)

Meningococcal carriage in the African meningitis belt
Publicado: (2013)

Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi
por: Negi, SS, et al.
Publicado: (2010)

Sequence Type 4821 Clonal Complex Serogroup B Neisseria meningitidis in China, 1978–2013
por: Zhu, Bingqing, et al.
Publicado: (2015)

Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine
por: Tsang, Raymond S. W., et al.
Publicado: (2020)

Clonal Groupings in Serogroup X Neisseria meningitidis
por: Gagneux, Sébastien, et al.
Publicado: (2002)

Neisseria meningitidis Serogroup W135 Sequence Type 11, Anhui Province, China, 2011–2013
por: Hu, Shoukui, et al.
Publicado: (2014)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
por: Strahilevitz, Jacob, et al.
Publicado: (2008)

Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil
por: de Filippis, Ivano, et al.
Publicado: (2012)

The Development of an Experimental Multiple Serogroups Vaccine for Neisseria meningitidis
por: Pinto, Valerian B., et al.
Publicado: (2013)

Neisseria meningitidis Serogroup W, Burkina Faso, 2012
por: MacNeil, Jessica R., et al.
Publicado: (2014)

Bacteraemic pneumonia caused by Neisseria meningitidis serogroup Y
por: Romero-Gomez, Maria Pilar, et al.
Publicado: (2011)

Neisseria meningitidis Serogroup X in Sub-Saharan Africa
por: Agnememel, Alain, et al.
Publicado: (2016)

Pericarditis due to Neisseria meningitidis serogroup W135
por: Shinha, Takashi, et al.
Publicado: (2018)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
por: Marshall, Gary S., et al.
Publicado: (2022)

Real-world impact and effectiveness of MenACWY-TT
por: Villena, Rodolfo, et al.
Publicado: (2023)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Whole-Genome Sequencing of Emerging Invasive Neisseria meningitidis Serogroup W in Sweden
por: Eriksson, Lorraine, et al.
Publicado: (2018)

Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020
por: Chiou, Chien-Shun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_antr4jctlgvv57epnope5969kb